Greenville, SC (FOX Carolina) - The first rounds of the COVID-19 have been administered across the nation. Here in South Carolina, December 15, 2020 has been referred to as V-Day by healthcare officials with Prisma Health, it s the day some front-line workers were vaccinated against the coronavirus. This vaccine is critically important, but it has long terms affects that we will have to wait to see, said Dr. Jessica Hobbs with Prisma.
Which has been a concern echoed across the country.
FOX Carolina s Jarvis Robertson spoke with an Allergist at Allergic Disease & Asthma Center who says his office has been inundated with calls wondering if the vaccine is safe, especially for people with allergies. According to Dr. Emmanuel Sarmiento, those with severe cases of anaphylaxis to insects, food or other medications are no more likely than the general public to have an allergic reaction to the COVID-19 vaccine.
Those administering COVID vaccine should be trained in use of EpiPen | Opinion
Updated Dec 17, 2020;
Posted Dec 17, 2020
Valerie Bolcar, a registered nurse at the Morristown, N.J., Medical Center, prepares to administer the COVID-19 vaccine to frontline workers on Tuesday.
Patti Sapone | NJ Advance Media
Facebook Share
By Robert K. Houton
The COVID-19 vaccination that began rolling out this week to frontline medical workers will hopefully end our long nightmare with this virus and the pandemic. But there is one concern: 1.6% of the American population, or roughly 5 million people, have experienced a severe allergic attack, called anaphylaxis, and may have a severe reaction to the vaccine.
Is the COVID-19 Vaccine Safe for Epi-Pen Users? 1490wosh.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 1490wosh.com Daily Mail and Mail on Sunday newspapers.
ACAAI releases guidance related to risk of allergic reactions to Pfizer-BioNTech COVID-19 vaccine
With the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine by the FDA on December 11, 2020, and distribution beginning today, the American College of Allergy, Asthma and Immunology COVID-19 Vaccine Task Force recommends the following guidance related to risk of an allergic reaction on vaccination for those who receive the vaccine. These recommendations are based on best knowledge to date but could change at any time, pending new information and further guidance from the FDA or CDC.
Allergic reactions to vaccines, in general, are rare with the incidence of anaphylaxis estimated at 1.31 in 1 million doses given.